Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rosiglitazone in Alzheimer's Disease
NCT00018382Phase 2Completed
- Sponsor
- United States Department of Veterans Affairs
- Start
- Oct 1999
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2 trial of rosiglitazone in Alzheimer's disease (AD), sponsored by United States Department of Veterans Affairs. Started Oct 1999; status: completed.
02
Drugs
rosiglitazone
03
Conditions
Alzheimer's disease (AD)
Beyond the preview
Go deeper on NCT00018382.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00018382.